Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia-bearing mice

British Journal of Haematology

Volumn 160, Issue 6, 2013, Pages 766-778

  Pessina, Augusto ^a   Coccè, Valentina ^a   Pascucci, Luisa ^b   Bonomi, Arianna ^a,c   Cavicchini, Loredana ^a   Sisto, Francesca ^a   Ferrari, Maura ^d   Ciusani, Emilio ^c   Crovace, Antonio ^e   Falchetti, Maria Laura ^f   Zicari, Sonia ^g   Caruso, Arnaldo ^g   Navone, Stefania ^c   Marfia, Giovanni ^c   Benetti, Anna ^g   Ceccarelli, Piero ^b   Parati, Eugenio ^c   Alessandri, Giulio ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c DEPARTMENT OF NEUROSURGERY   (Italy)

^d ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLA LOMBARDIA E DELL EMILIA ROMAGNA   (Italy)

^e UNIVERSITY OF BARI   (Italy)

^f CNR   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Leukaemia; Mesenchymal stem cells; Paclitaxel

Indexed keywords

CHEMOTACTIC FACTOR; INTERCELLULAR ADHESION MOLECULE 1; PACLITAXEL; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ADHESION; CELL DEATH; CELL KILLING; CELL THERAPY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; LEUKEMIA CELL; LEUKEMIA CELL LINE; LEUKEMIA L 1210; MALE; MESENCHYMAL STROMA CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; VASCULAR ENDOTHELIUM;

ANIMALS; CELL COMMUNICATION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HUMANS; LEUKEMIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84874684335     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12196     Document Type: Article

References (49)

1. Aizawa, S., Hojo, H., Tsuda, A., Sai, M. & Toyama, K. (1991) Rosette formation between stromal and hemopoietic cell: a simple assay for the supportive activity of stromal cells. Leukemia, 5, 273-276.
2. Belotti, D., Vergani, V., Drudis, T., Borsotti, P., Pitelli, M.R., Viale, G., Giavazzi, R. & Taraboletti, G. (1996) The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clinical Cancer Research, 2, 1843-1849.
3. Benetti, A., Berenzi, A., Gambarotti, M., Garrafa, E., Gelati, M., Dessy, E., Portolani, N., Piardi, T., Giulini, S.M., Caruso, A., Invernici, G., Parati, E.A., Nicosia, R. & Alessandri, G. (2008) Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium. Cancer Research, 68, 8626-8634.
4. Bergfeld, S.A. & DeClerck, Y.A. (2010) Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer and Metastasis Reviews, 29 249-261.
5. Blasi, A., Martino, C., Balducci, L., Saldarelli, M., Soleti, A., Navone, S.E., Canzi, L., Cristini, S., Invernici, G., Parati, E. & Alessandri, G. (2011) Dermal fibroblasts display similar phenotypic and differentiation capacity to fat-derived mesenchymal stem cells, but differ in anti-inflammatory and angiogenic potential. Vascular Cell, 3, 5.
6. Burger, J.A. & Kipps, T.J. (2002) Chemokine receptors and stromal cells in the homing and homeostasis of chronic lymphocytic leukemia B cells. Leukemia & Lymphoma, 43, 461-466.
7. Caruso, A., Fiorentini, S., Licenziati, S., Alessandri, G., Ricotta, D., Imberti, L., Signorini, S., Armenta-Solis, A., Garrafa, E., Balsari, A. & Turano, A. (2000) Expansion of rare CD8+ CD28- CD11b- T cells with impaired effector functions in HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes, 24, 465-474.
8. Cook, G., Dumbar, M. & Franklin, I.M. (1997) The role of adhesion molecules in multiple myeloma. Acta Haematologica, 97, 81-89.
9. Damiano, J.S., Cress, A.E., Hazlehurst, L.A., Shtil, A.A. & Dalton, W.S. (1999) Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood, 93, 1658-1667.
10. Dhar, S., Gu, F.X., Langer, R., Farokhzad, O.C. & Lippard, S.J. (2008) Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt (IV) prodrug-PLGA-PEG nanoparticles. Proceedings of the National Academy of Sciences USA, 105, 17356-17361.
11. Dull, T., Zufferey, R., Kelly, M., Mandel, R.J., Nguyen, M., Trono, D. & Naldini, L. (1998) A third-generation lentivirus vector with a conditional packaging system. Journal of Virology, 72, 8463-8471.
12. Erba, E., Serafini, M., Gaipa, G., Tognon, G., Marchini, S., Celli, N., Rotilio, G., Broggini, M., Jimeno, J., Faircloth, G.T., Biondi, A. & D'Incalci, M. (2003) Effect of Aplidin in acute lymphoblastic leukemia cells. British Journal of Cancer, 89, 763-773.
13. Falchetti, M.L., Mongiardi, M.P., Fiorenzo, P., Petrucci, G., Pierconti, F., D'Agnano, I., D'Alessandris, G., Alessandri, G., Gelati, M., Ricci-Vitiani, L., Maira, G., Larocca, L.M., Levi, A. & Pallini, R. (2008) Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts. International Journal of Cancer, 122, 1236-1242.
14. Gale, K.B., Ford, A.M., Repp, R., Borkhardt, A., Keller, C., Eden, O.B. & Greaves, M.F. (1997) Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proceedings of the National Academy of Sciences USA, 94, 13950-13954.
15. Gasparini, G. & Harris, A.R. (1995) Clinical importance of the determination of tumours angiogenesis in breast carcinoma: much more than a new prognostic tool. Journal of Clinical Oncology, 13, 765-782.
16. Hayat, M.F. (2000) Principles and techniques of electron microscopy. Biological Applications, 4th edn. Cambridge University Press, Cambridge.
17. He, R., Liu, B., Yang, C., Yang, R.C., Tobelem, G. & Han, Z.C. (2003) Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence. Cancer Gene Theraphy, 10, 879-886.
18. Klopp, A.H., Gupta, A., Spaeth, E., Andreeff, M. & Marini, F. III (2011) Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells, 29, 11-19.
19. Kucerova, L., Matuskova, M., Hlubinova, K., Altanerova, V. & Altaner, C. (2010) Tumor cell behaviour modulation by mesenchymal stromal cells. Molecular Cancer, 9, 129.
20. Law, L.W., Dunn, T.B., Boyle, P.J. & Miller, J.H. (1949) Observations on the effect of a folic acid antagonist on transplantable lymphoid leukemias in mice. Journal of the National Cancer Institute, 10, 179-192.
21. Levi, F., La Vecchia, C., Negri, E. & Lucchini, F. (2001) Childhood cancer mortality in Europe, 1955-1995. European Journal of Cancer, 37, 785-809.
22. Li, L., Tian, H., Yue, W., Zhu, F., Li, S. & Li, W. (2011) Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo. Journal of Cellular Physiology, 226, 1860-1867.
23. Loubani, O. & Hoskin, D.W. (2005) Paclitaxel inhibits natural killer cell binding to target cells by down-regulating adhesion molecule expression. Anticancer Research, 25, 735-741.
24. Minowada, J., Onuma, T. & Moore, G.E. (1972) Rosette-forming human lymphoid cell lines Establishment and evidence for origin of thymus-derived lymphocytes. Journal of the National Cancer Institute, 49, 891-895.
25. Mossman, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55-63.
26. Narod, S.A., Hawkins, M.M., Robertson, C.M. & Stiller, C.A. (1997) Congenital anomalies and childhood cancer in Great Britain. The American Journal of Human Genetics, 60, 474-485.
27. Nomura, K., ed. (2006) Cancer Statistics in Japan 2005. Foundation for Promotion Cancer Research, Tokyo, Japan.
28. Pessina, A., Mineo, E., Neri, M.G., Gribaldo, L., Colombi, R., Brambilla, P. & Zaleskis, G. (1992) Establishment and characterization of a new murine cell line (SR4987) derived from marrow stromal cells. Cytotechnology, 8, 93-102.
29. Pessina, A., Eletti, B., Croera, C., Savalli, N., Diodovich, C. & Gribaldo, L. (2004) Pancreas developing markers expressed on human mononucleated umbilical cord blood cells. Biochemical and Biophysical Research Communications, 323, 315-322.
30. Pessina, A., Bonomi, A., Coccè, V., Invernici, G., Navone, S., Cavicchini, L., Sisto, F., Ferrari, M., Viganò, L., Locatelli, A., Ciusani, E., Cappelletti, G., Cartelli, D., Arnaldo, C., Parati, E., Marfia, G., Pallini, R., Falchetti, M.L. & Alessandri, G. (2011a) Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy. PLoS ONE, 6, e28321.
31. Pessina, A., Sisto, F., Coccè, V., Cavicchini, L., Ciusani, E., Gribaldo, L. & Bonomi, A. (2011b) A mesenchymal stromal cell line resistant to paclitaxel that spontaneously differentiates into osteoblast-like cells. Cell Biology and Toxicology, 27, 169-180.
32. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Graig, S. & Marshak, D.R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
33. Prantl, L., Muehlberg, F., Navone, N.M., Song, Y.H., Vykoukal, J., Logothetis, C.J. & Alt, E.U. (2010) Adipose tissue-derived stem cells promote prostate tumor growth. Prostate, 70, 1709-1715.
34. Ramasamy, R., Lam, E.W., Soeiro, I., Tisato, V., Bonnet, D. & Dazzi, F. (2007) Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia, 21, 304-310.
35. Reed, L.J. & Muench, H. (1938) A simple method of estimating fifty percent endpoints. The American Journal of Hygiene, 27, 493-497.
36. Schichor, C., Albrecht, V., Korte, B., Buchner, A., Riesenberg, R., Mysliwietz, J., Paron, I., Motaln, H., Turnšek, T.L., Jürchott, K., Selbig, J. & Tonn, J.C. (2012) Mesenchymal stem cells and glioma cells form a structural as well as a functional syncytium in vitro. Experimental Neurology, 234, 208-219.
37. Schiff, P.B., Fant, J. & Horwitz, S.B. (1979) Promotion of microtubule assembly in vitro by taxol. Nature, 277, 665-667.
38. Shain, K.H., Yarde, D.N., Meads, M.B., Huang, M., Jove, R., Hazlehurst, L.A. & Dalton, W.S. (2009) Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation. Cancer Research, 69, 1009-1015.
39. Shinagawa, K., Kitadai, Y., Tanaka, M., Sumida, T., Kodama, M., Higasci, Y., Tanaka, S., Yasui, W. & Chayama, K. (2010) Mesenchymal stem cells enhance growth and metastasis of colon cancer. International Journal of Cancer, 127, 2323-2333.
40. Stiller, C.A. (2007) International patterns of cancer incidence in adolescents. Cancer Treatment Reviews, 33, 631-645.
41. Till, K.J., Lin, K., Zuzel, M. & Cawley, J.C. (2002) The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes. Blood, 99, 2977-2984.
42. Trinidad, E.M., Ballesteros, M., Zuloaga, J., Zapata, A. & Alonso-Colmenar, L.M. (2009) An impaired transendothelial migration potential of chronic lymphocytic leukemia (CLL) cells can be linked to ephrin-A4 expression. Blood, 114, 5081-5090.
43. Urashima, M., Chen, B.P., Chen, S., Pinkus, G.S., Bronson, R.T., Dedera, D.A., Hoshi, Y., Teoh, G., Ogata, A., Treon, S.P., Chaudan, D. & Anderson, K.C. (1997) The development of a model for the homing of multiple myeloma cells to human bone marrow. Blood, 90, 754-765.
44. Wang, H., Cao, F., De, A., Cao, Y., Contag, C., Gambhir, S.S., Wu, J.C. & Chen, X. (2009) Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells, 27, 1548-1558.
45. Wei, Z., Chen, N., Guo, H., Wang, X., Xu, F., Ren, Q., Lu, S., Liu, B., Zhang, L. & Zhao, H. (2009) Bone marrow mesenchymal stem cells from leukemia patients inhibit growth and apoptosis in serum-deprived K562 cells. Journal of Experimental & Clinical Cancer Research, 28, 141.
46. Weldon, J.E., Xiang, L., Chertov, O., Margulies, I., Kreitman, R.J., Fitzgerald, D.J. & Pastan, I. (2009) A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity. Blood, 113, 3792-3800.
47. WHO. (2010) World Health Organization Mortality Database 2010. Available from http://www.who.int/healthinfo/morttables/en/. Accessed on 25 February 2010.
48. Zhu, W., Xu, W., Jiang, R., Qian, H. & Chen, Y. (2006) Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Experimental and Molecular Pathology, 80, 267-274.
49. Zhu, Y., Sun, Z., Han, Q., Liao, L., Wang, J., Bian, C., Li, J., Yan, X., Liu, Y., Shao, C. & Zhao, R.C. (2009) Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia, 23, 925-933.